Schrodinger has won U.S. Food and Drug Administration fast-track designation for its SGR-1505 drug candidate in a rare type of non-Hodgkin's lymphoma.

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

Advocates for veterans are championing Assembly Bill 1103, which would fast-track the approval of academic studies on ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx ...

In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, ...

Healthy volunteers were given either ISLA-101 or a placebo, then deliberately exposed to a weakened strain of dengue virus.

FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.

The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to-consumer offering.

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

SandboxAQ releases over 5 million AI-generated protein-drug structures to accelerate drug discovery and rival lab testing.

Food and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...

We are pleased to receive fast track designation from the FDA in recognition of the MELAS community’s unmet medical needs and ...